ES2063963T3 - Nuevas ariloxi-alquilaminas, su preparacion y medicamentos que las contienen. - Google Patents

Nuevas ariloxi-alquilaminas, su preparacion y medicamentos que las contienen.

Info

Publication number
ES2063963T3
ES2063963T3 ES90904270T ES90904270T ES2063963T3 ES 2063963 T3 ES2063963 T3 ES 2063963T3 ES 90904270 T ES90904270 T ES 90904270T ES 90904270 T ES90904270 T ES 90904270T ES 2063963 T3 ES2063963 T3 ES 2063963T3
Authority
ES
Spain
Prior art keywords
pct
alkyl
ring
nitrogen atom
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90904270T
Other languages
English (en)
Inventor
Bernhard Lotz
Gerhard Greier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laevosan GmbH and Co KG
Original Assignee
Laevosan GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan GmbH and Co KG filed Critical Laevosan GmbH and Co KG
Application granted granted Critical
Publication of ES2063963T3 publication Critical patent/ES2063963T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/36Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

NUEVOS DERIVADOS DE ALQUILAMINA OXIARILICA QUE TIENEN LA FORMULA GENERAL (I), EN QUE A ES UN ANILLO DE BENZOL O DE TIOFENO; R Y R SUB 1 SON CADA UNO INDEPENDIENTEMENTE HIDROGENO, ALQUILO, HALOGENO CF SUB 3 O ALCOXI; R SUB 2 ES ALQUILO, CICLOALQUILO, ALQUENILO, ALQUINILO O ACILO AROMATICO O ALIFATICO SATURADO O NO SATURADO, R SUB 3 Y R SUB 4 SON HIDROGENO, ALQUILO, ALQUENILO, ALQUINILO O CICLOALQUILO CON HASTA 8 ATOMOS DE CARBONO , EN QUE R SUB 3 Y R SUB 4 PUEDEN SER IGUALES O DIFERENTES, PERO NO PUEDEN SER HIDROGENO AL MISMO TIEMPO, O EN QUE R SUB 3 Y R SUB 4 JUNTO CON LOS ATOMOS DE NITROGENO QUE LOS ENLAZAN FORMAN UN ANILLO SATURADO DE 5 A 7 MIEMBROS O UN ANILLO HETEROCICLICO SATURADO QUE PUEDE CONTENER UN ATOMO DE OXIGENO O DE NITROGENO COMO HETEROATOMO ADICIONAL EN EL ANILLO, DONDE UN ATOMO DE NITROGENO ADICIONAL PUEDE SER SUSTITUIDO POR UN RADICAL DE ALQUILO CON HASTA 3 ATOMOS DE CARBONO. ESTOS DERIVADOS DE AMINA Y SUS SALES DE ADICION ACIDAS TIENEN UNAS PROPIEDADES FARMACEUTICAS INTERESANTES Y SON ESPECIALMENTE APTAS COMO ANTI-ARRITMICOS.
ES90904270T 1989-03-08 1990-03-08 Nuevas ariloxi-alquilaminas, su preparacion y medicamentos que las contienen. Expired - Lifetime ES2063963T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3907512A DE3907512C2 (de) 1989-03-08 1989-03-08 Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES2063963T3 true ES2063963T3 (es) 1995-01-16

Family

ID=6375847

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90904270T Expired - Lifetime ES2063963T3 (es) 1989-03-08 1990-03-08 Nuevas ariloxi-alquilaminas, su preparacion y medicamentos que las contienen.

Country Status (9)

Country Link
US (1) US5334602A (es)
EP (1) EP0462150B1 (es)
JP (1) JP2825643B2 (es)
AT (1) ATE111096T1 (es)
CA (1) CA2048626A1 (es)
DE (2) DE3907512C2 (es)
DK (1) DK0462150T3 (es)
ES (1) ES2063963T3 (es)
WO (1) WO1990010628A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218541D0 (en) 1991-09-30 1992-10-14 Ici Plc Fungicides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2001431C3 (de) * 1970-01-06 1974-12-12 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-(2'-Hydroxy-3'-alkylaminopropoxy)-Omega-phenyl-propiophenone und Verfahren zur Herstellung derselben
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
FI76551C (fi) * 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
AT369739B (de) * 1980-11-28 1983-01-25 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer 1-(3-(2-hydroxy-3alkylaminopropoxy)-2-thienyl)-3-phenyl-1- propanone und ihrer saeureadditionssalze
DE3133814C2 (de) * 1981-08-25 1983-12-22 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-β-phenylpropiophenon, seine Säureadditionssalze und Arzneimittel
DE3328376A1 (de) * 1983-07-21 1985-01-31 Helopharm W. Petrik & Co Kg, 1000 Berlin Aminopropanolderivate von 2-hydroxy-ss-phenyl-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS62178585A (ja) * 1986-01-29 1987-08-05 レフオ−サン−ゲゼルシヤフト エム・ベ−・ハ− 1−〔3−(2−ヒドロキシ−3−アルキルアミノプロポキシ)−2−チエニル〕−3−フエニル−1−プロパノン及びそれらの酸付加塩並びにそれらの製造法及びそれらを含む薬学的組成物
DE3834132A1 (de) * 1988-10-07 1990-04-12 Knoll Ag Hydroxypropafenonglyceride
AT392967B (de) * 1989-01-24 1991-07-25 Laevosan Gmbh & Co Kg Neue 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2- thienyl)-3-phenyl-1-propanone und verfahren zu deren herstellung
DE3911069A1 (de) * 1989-04-06 1990-10-11 Knoll Ag Einkristalle von ss-phenylpropiophenonen
DE4000213A1 (de) * 1990-01-05 1991-07-11 Helopharm Petrik Co Kg O-hydroxy-ss-(1-naphthyl)-propiophenonderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0462150B1 (de) 1994-09-07
DE3907512A1 (de) 1990-09-20
JP2825643B2 (ja) 1998-11-18
US5334602A (en) 1994-08-02
DE59007074D1 (de) 1994-10-13
DE3907512C2 (de) 1997-08-14
CA2048626A1 (en) 1990-09-09
EP0462150A1 (de) 1991-12-27
WO1990010628A1 (de) 1990-09-20
DK0462150T3 (da) 1995-02-13
ATE111096T1 (de) 1994-09-15
JPH04504113A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
MX9200344A (es) Derivados de benzamida, proceso para su preparacion y composicion farmaceutica que los contiene.
ATE186724T1 (de) Substituierte thiazolidindionderivate
ES2066875T3 (es) Aminoalquilindoles, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
SE7908995L (sv) Heterocykliska foreningar
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
DE69101067D1 (de) Aminomethylpiperidinderivate, deren Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
ES2053643T3 (es) Procedimiento para producir fotoestabilizadores a base de amina impedida fijada a polimero.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9304467A (es) Nuevos derivados fosfonados de ariletanolaminas, procedimiento para su preparacion y composiciones farmaceuticas y veterinarias que los contienen.
DE3784642D1 (de) Verwendung von aromatischen carbonsaeureamiden.
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FI910924A0 (fi) Nya propanaminer, framstaellning av dessa och anvaendning av dessa foer terapeutiska aendamaol, i synnerhet som diarremediciner.
DE68906965D1 (de) Analgetische phenothiazinderivate.
ES2063963T3 (es) Nuevas ariloxi-alquilaminas, su preparacion y medicamentos que las contienen.
ES2071458T3 (es) Nuevos compuestos amidicos de 1-(alcoxi-bencil)-piperacinas, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
FR2449677A1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
NZ223180A (en) Guanidinoacetic and ethanamidinoacetic acid derivatives and sweetening compositions
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2063157T3 (es) Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462150

Country of ref document: ES